South San Francisco, CA, United States of America

Klaus Hoeflich



 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 52(Granted Patents)


Location History:

  • San Mateo, CA (US) (2012)
  • South San Francisco, CA (US) (2013 - 2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Klaus Hoeflich: Innovator in Cancer Treatment

Introduction

Klaus Hoeflich is a prominent inventor based in South San Francisco, CA, known for his significant contributions to cancer treatment through innovative pharmaceutical combinations. With a total of 3 patents, he has made strides in the field of oncology, focusing on the development of effective therapeutic methods.

Latest Patents

Hoeflich's latest patents include groundbreaking inventions that combine AKT inhibitor compounds with vemurafenib. This invention provides a combination of a compound of Formula Ia, or a pharmaceutically acceptable salt thereof, and vemurafenib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of hyperproliferative disorders, such as cancer. Another notable patent involves combinations of phosphoinositide 3-kinase (PI3K) inhibitor compounds with chemotherapeutic agents. This patent details the use of PI3K inhibitor compounds having Formulas I and II, along with various chemotherapeutic agents, for treating hyperproliferative disorders, including cancer.

Career Highlights

Throughout his career, Klaus Hoeflich has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. His work has been instrumental in advancing cancer therapies and improving patient outcomes.

Collaborations

Hoeflich has collaborated with notable colleagues, including Marcia Belvin and Lori Friedman, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Klaus Hoeflich's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a key figure in the field of oncology. His work continues to inspire advancements in therapeutic methods for hyperproliferative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…